ArticleMagma (New York, N.Y.)2013
PET/MRI in cancer patients: first experiences and vision from Copenhagen.
Article in Magma (New York, N.Y.), 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
14 citing papers in PubMed.
- The prognostic value of positron emission tomography/magnetic resonance imaging in predicting survival in patients with adenocarcinoma of the esophagogastric junction.Annals of nuclear medicine · 2025Article
- Recent advances in radionuclide medical imaging techniques.Frontiers in medicine · 2025Review
- Magnetic Fields and Cancer: Epidemiology, Cellular Biology, and Theranostics.International journal of molecular sciences · 2022Review
- Cervical cancer evaluated with integratedOncology letters · 2019Article
- Diagnostic performance of PET/MR in the evaluation of active inflammation in Crohn disease.American journal of nuclear medicine and molecular imaging · 2018Article
- Simultaneous PET/MR imaging with a radio frequency-penetrable PET insert.Medical physics · 2017Article
- Dental artifacts in the head and neck region: implications for Dixon-based attenuation correction in PET/MR.EJNMMI physics · 2015Article
- A Clinical and Experimental Comparison of Time of Flight PET/MRI and PET/CT Systems.Molecular imaging and biology · 2015Article
- Preoperative imaging for staging bladder cancer.Current urology reports · 2015Review
- Simultaneous hyperpolarized (13)C-pyruvate MRI and (18)F-FDG-PET in cancer (hyperPET): feasibility of a new imaging concept using a clinical PET/MRI scanner.American journal of nuclear medicine and molecular imaging · 2015Article
- MR-PET of the body: Early experience and insights.European journal of radiology open · 2014Review
- Does the novel integrated PET/MRI offer the same diagnostic performance as PET/CT for oncological indications?PloS one · 2014Article
- Competitive advantage of PET/MRI.European journal of radiology · 2014Review
- MR/PET or PET/MRI: does it matter?Magma (New York, N.Y.) · 2013Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Combined PET/MRI systems are now commercially available and are expected to change the medical imaging field by providing combined anato-metabolic image information. We believe this will be of particular relevance in imaging of cancer patients. At the Department of Clinical Physiology, Nuclear Medicine & PET at Rigshospitalet in Copenhagen we installed an integrated PET/MRI in December 2011. Here, we describe our first clinical PET/MR cases and discuss some of the areas within oncology where we envision promising future application of integrated PET/MR imaging in clinical routine. Cases described include brain tumors, pediatric oncology as well as lung, abdominal and pelvic cancer. In general the cases show that PET/MRI performs well in all these types of cancer when compared to PET/CT. However, future large-scale clinical studies are needed to establish when to use PET/MRI. We envision that PET/MRI in oncology will prove to become a valuable addition to PET/CT in diagnosing, tailoring and monitoring cancer therapy in selected patient populations.
Indexed as
Identifiers
23266511What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.